- Home
- Advocacy
- Latest News and Practice Data
- Register for CAPs Upcoming LDT Webinar: Ready Your Laboratory for the FDA’s Stage 1: Adverse Event Reporting Requirement
Under the FDA regulation, laboratories with LDTs must have a process in place for adverse event reporting starting May 6, 2025. The CAP’s second webinar in its series focused on implementation of the rule will discuss existing accreditation requirements and ways laboratories can comply with the FDA rules on medical device-related adverse event reporting. Accreditation experts will review best practices associated with quality management and discuss real world scenarios. Join the webinar on November 7, from Noon - 1 PM CT to learn more!
Speakers
- Bobbi S. Pritt, MD, FCAP, chair, Council on Scientific Affairs
- Earle S. Collum, MD, FCAP, vice chair, Council on Accreditation
Watch a recording of the first webinar, Understanding the Impact of the FDA’s LDT Risk Classification on Your Laboratory by clicking here.